View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

One Stop Systems to Report First Quarter 2024 Financial Results

One Stop Systems to Report First Quarter 2024 Financial Results Conference Call to be Held Thursday, May 9, 2024, at 5:00 p.m. ET ESCONDIDO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the "Company") (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, announced today that the Company will release its first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. A webcast and conference call will be held that same day at 5:00 p.m. ET t...

 PRESS RELEASE

Airship AI Announces $2.35 Million Sole-Source Contract Award within t...

Airship AI Announces $2.35 Million Sole-Source Contract Award within the Department of Justice for Outpost AI Edge Appliances Previously Announced Award for Airship AI’s Acropolis Enterprise Video and Data Management Platform in the FedRAMP Environment Successfully Developed into Additional DOJ Award for Outpost AI REDMOND, Wash., April 25, 2024 (GLOBE NEWSWIRE) -- Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in AI-driven video, sensor, and data management surveillance solutions, has been awarded a multi-million dollar contract to an agency within t...

 PRESS RELEASE

Journey Medical Corporation to Present at the Planet MicroCap Showcase...

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, announced today that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap...

 PRESS RELEASE

Calian Wins $23 Million Contract for New Military Medical Training Pro...

Calian Wins $23 Million Contract for New Military Medical Training Program with the Canadian Armed Forces OTTAWA, April 25, 2024 (GLOBE NEWSWIRE) -- Calian Group Ltd. (TSX: CGY), a provider of diverse and innovative solutions in healthcare, communications, learning and cybersecurity, has been awarded a significant contract by the Canadian Armed Forces' Canadian Forces Health Services Group (CFHSG). Valued at $17 million for three years with an option to extend for a fourth year, potentially increasing the total value to $23 million, this contract highlights Calian’s commitment to leveragi...

 PRESS RELEASE

Star Equity Holdings Announces its KBS Builders Business Unit Closed a...

Star Equity Holdings Announces its KBS Builders Business Unit Closed a $4 Million Revolving Line of Credit with KeyBank OLD GREENWICH, Conn., April 25, 2024 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star” or the “Company”), a diversified holding company, announced today that its KBS Builders, Inc. (“KBS”) business unit has closed a $4 million revolving line of credit (“LOC”) with KeyBank National Association (“KeyBank”). KBS intends to use the LOC to meet its working capital requirements and execute its business plan. The closing of this LOC provides both KBS ...

Kuehne + Nagel International AG: 1 director

A director at Kuehne + Nagel International AG bought 4,100 shares at 243.504CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...

Ancom Nylex Berhad: 2 directors

Two Directors at Ancom Nylex Berhad bought/sold 4,000,000 shares at 1.040MYR. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...

ABGSC Construct. & Real Estate Research ... (+4)
  • ABGSC Construct. & Real Estate Research
  • Fredrik Stensved
  • Markus Henriksson
  • Viktor Stenlöf
 PRESS RELEASE

Hanmi Financial Declares Cash Dividend of $0.25 per share and Announce...

Hanmi Financial Declares Cash Dividend of $0.25 per share and Announces New Share Repurchase Authorization LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced that its Board of Directors declared a cash dividend on its common stock for the 2024 second quarter of $0.25 per share. The dividend will be paid on May 22, 2024, to stockholders of record as of the close of business on May 6, 2024. In addition, the Board of Directors today approved a new stock repurchase program. Und...

 PRESS RELEASE

Ladder Capital Corp Reports Results for the Quarter Ended March 31, 20...

NEW YORK--(BUSINESS WIRE)-- Ladder Capital Corp (NYSE: LADR) (“we,” “our,” “Ladder,” or the “Company”) today announced operating results for the quarter ended March 31, 2024. GAAP income before taxes for the three months ended March 31, 2024 was $18.4 million, and diluted earnings per share (“EPS”) was $0.13. Distributable earnings was $42.3 million, or $0.33 of distributable EPS. “We are pleased with Ladder’s first quarter results, as we continue to navigate through the current credit cycle, increased global tensions, heightened market volatility, and persistently high interest rates. With ...

 PRESS RELEASE

Kearny Financial Corp. Announces Third Quarter Fiscal 2024 Results and...

Kearny Financial Corp. Announces Third Quarter Fiscal 2024 Results and Declaration of Cash Dividend FAIRFIELD, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company of Kearny Bank (the “Bank”), reported net income for the quarter ended March 31, 2024 of $7.4 million, or $0.12 per diluted share, compared to a net loss of $13.8 million, or $0.22 per diluted share, for the quarter ended December 31, 2023. The net loss for the quarter ended December 31, 2023 was impacted by various non-recurring items, as previously disclosed. ...

 PRESS RELEASE

Veru to Present at the American Association of Clinical Endocrinology ...

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11 MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that the Company will present two late-breaking abstract presentations at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting, taking place May 9-11, 2024 in New Or...

 PRESS RELEASE

Apollomics Announces Approval of Vebreltinib in China as a First-in-Cl...

Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene Apollomics’ partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion gene Approval based on results from a randomized Phase 2/3 trial FOSTER CITY, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant ca...

 PRESS RELEASE

West Bancorporation, Inc. Announces First Quarter 2024 Financial Resul...

West Bancorporation, Inc. Announces First Quarter 2024 Financial Results and Declares Quarterly Dividend WEST DES MOINES, Iowa, April 25, 2024 (GLOBE NEWSWIRE) -- West Bancorporation, Inc. (Nasdaq: WTBA; the “Company”), parent company of West Bank, today reported first quarter 2024 net income of $5.8 million, or $0.35 per diluted common share, compared to fourth quarter 2023 net income of $4.5 million, or $0.27 per diluted common share, and first quarter 2023 net income of $7.8 million, or $0.47 per diluted common share. On April 24, 2024, the Company’s Board of Directors declared a regul...

 PRESS RELEASE

Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preve...

Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care Provides MangoRx with entrance into the non-Rx based, nutraceutical product space for sales on both direct-to-consumer online platforms and through retail locations Dallas, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce that it has acquired...

 PRESS RELEASE

Navitas Highlights EV High-speed Hybrid Power Semiconductor Advances i...

Navitas Highlights EV High-speed Hybrid Power Semiconductor Advances in China Innovation Summit Keynote No-compromise, next-gen GaN and SiC technologies drive faster EV charging, longer range and lower system costs TORRANCE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, today announced its participation in forthcoming in Shenzhen on April 27th. The summit gathers key players in power semiconductors and associated customer design teams for innovati...

 PRESS RELEASE

SoundThinking Sets First Quarter 2024 Conference Call for Tuesday, May...

SoundThinking Sets First Quarter 2024 Conference Call for Tuesday, May 14, 2024 at 4:30 p.m. ET FREMONT, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SSTI) (formerly ShotSpotter, Inc.), a leading public safety technology company, will hold a conference call on Tuesday, May 14, 2024 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be issued in a press release prior to the call. SoundThinking management will host the presentation, followed by a question-and-answer period. Date...

 PRESS RELEASE

New Season of Gaia Original Series The Journey of Remembering with Mat...

New Season of Gaia Original Series The Journey of Remembering with Matías De Stefano Returned Monday, April 22 BOULDER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, announced that the second season of its highly-anticipated original series The Journey of Remembering is now available exclusively on Gaia. The premiere of this eight-episode series includes the first three episodes, with new episodes released each Monday at 2:00 a.m. MT. In season two of this exclusive Gaia Original docuseries, Matías De Stefano guides 45 ini...

 PRESS RELEASE

AMMO, Inc. Announces Acquisition of Tooling Manufacturer

AMMO, Inc. Announces Acquisition of Tooling Manufacturer Insourcing of tool manufacturing expected to achieve over$1 million in annualized cost savings SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically integrated producer of high-performance ammunition and components, announces that it has acquired a tooling manufacturer that provides key resources toward the production of ammunition...

 PRESS RELEASE

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Dev...

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip THE WOODLANDS, TX, April 25, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it has entered into a service agreement with NoiseFigure Research, Inc. (NFR), a premier application specific integrated circuits (ASICs) service provider. As part of the agreement, Autonomix w...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch